This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Journey Medical Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Bijay Kumar Padhi in Treating Inflammatory Skin Conditions
Introduction
Bijay Kumar Padhi is an accomplished inventor based in Odisha, India. He has made significant contributions to the field of dermatology through his innovative approaches to treating inflammatory skin conditions. His work exemplifies the intersection of science and healthcare, aiming to improve the quality of life for individuals suffering from such ailments.
Latest Patents
Bijay Kumar Padhi holds a patent for a method of treating inflammatory skin conditions. The patent, titled "Methods for treating inflammatory skin conditions," describes a pharmaceutical composition that utilizes a reduced dose of minocycline. This method effectively administers the drug to achieve optimal plasma or interstitial fluid concentrations, thereby providing a therapeutic benefit to patients in need.
Career Highlights
Padhi is currently associated with Journey Medical Corporation, where he continues to develop and refine his innovative ideas. His dedication to research and development has positioned him as a key player in the medical field, particularly in dermatological treatments. His work not only reflects his expertise but also his commitment to advancing medical science.
Collaborations
Some of his notable coworkers include Shanvas Alikunju and Swati Kulkarni. Their collaborative efforts contribute to a dynamic work environment that fosters innovation and creativity in addressing complex medical challenges.
Conclusion
Bijay Kumar Padhi's contributions to the treatment of inflammatory skin conditions highlight the importance of innovation in healthcare. His patent and ongoing work at Journey Medical Corporation demonstrate his commitment to improving patient outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile